During the first wave of the COVID-19 outbreak that erupted in China in late 2019, Dr Ning ZHOU, a cardiologist in Wuhan city, contracted the virus. He eventually recovered, and after several weeks in quarantine, he went back to work to care for the thousands of patients that flooded the local hospitals. Other healthcare workers were not so […]
COVID-19 in Wuhan: local cardiologist shares frontline experience Read More »
On 17 Apr 2020, the Asia Pacific Society of Cardiology (APSC) hosted a webinar on the interplay between the COVID-19 pandemic and cardiology. The webinar, which was endorsed by the International Society of Cardiovascular Pharmacotherapy and supported by Roche Diagnostics, attracted nearly 500 participants from across Asia and around the world. The webinar was moderated by
COVID-19 and the heart: experiences from the frontline Read More »
On 11 Apr 2020, Dr Bi Jie HU, a Professor and Head of Department of Infectious Diseases and Hospital Infection Management at Zhongshan Hospital, gave a video presentation about his recent experience as a clinician during the ongoing COVID-19 outbreak in China. The presentation included valuable commentary on how Zhongshan Hospital, a major tertiary teaching institution affiliated with Fudan University
COVID-19 pneumonia experience from China: diagnosis, treatment and PPE Read More »
On 11 Apr 2020, the Asia Pacific Association of Critical Care Medicine (APACCM) co-hosted a webinar with Roche Diagnostics on the management of severe COVID-19 pneumonia. The webinar included presentations from two clinicians on the frontlines of the outbreak in China: Dr Hu Bie Jie – Professor, Head of Department of Infectious Diseases and Hospital Infection Management, Zhongshan Hospital,
Management of severe COVID-19 pneumonia: experiences from the frontline (webinar) Read More »
NT-proBNP has been proven to be a useful biomarker for prognostic evaluation of chronic heart failure patients, but it remains unclear how prognostic evidence can be translated into clinical practice to enhance heart failure management. The Asia Pacific Cardiac Webinar brings together global and regional experts to discuss the practical use of NT-proBNP as a
HPV DNA testing is shown to be significantly more effective compared to pap smear/cytology for cervical cancer screening. In this webinar, you will learn how to implement HPV DNA testing as a primary screening tool for cervical cancer. How to address multidisciplinary challenges during the transition phase from pap smear/cytology to HPV DNA testing? What are the considerations
How to implement HPV DNA testing as a primary screening tool? Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
